Rhenman & Partners Asset Management AB - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,992,600
-31.7%
180,0000.0%0.22%
-30.2%
Q2 2023$2,917,800
-6.5%
180,0000.0%0.31%
-9.9%
Q1 2023$3,119,400
+233.3%
180,000
-10.0%
0.34%
+161.1%
Q1 2020$936,000
-41.6%
200,0000.0%0.13%
-25.6%
Q4 2019$1,604,000
+16.6%
200,0000.0%0.18%
+2.3%
Q3 2019$1,376,000
-43.1%
200,000
-31.4%
0.17%
-35.3%
Q2 2019$2,419,000291,4990.27%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders